SCHEMBL1649543

SCHEMBL1649543

O=C(O)CCCCCCCCCCC(Br)NC(=O)c1ccncc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.59
CYP2C19 P33261 2/20 0.59
CYP2C9 P11712 1/20 0.59
ALDH1A1 P00352 2/20 0.46
MAPK1 P28482 2/20 0.44
TBXAS1 P24557 3/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MPO P05164 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2A6 P11509 1/20 0.42
EPHX2 P34913 1/20 0.42
NAAA Q02083 1/20 0.40
TBK1 Q9UHD2 1/20 0.40
HDAC4 P56524 1/20 0.40
MEF2D Q14814 1/20 0.40
PRKACA P17612 2/20 0.40
GSK3A P49840 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2364024 0.77 CYP1A2 (0.55) CYP1A2CYP2C19CYP2C9ALDH1A1MAPK1
SCHEMBL10102739 0.75 CYP1A2 (1.00) CYP1A2CYP2C19CYP2C9ALDH1A1MAPK1
SCHEMBL23303777 0.74 CA2 (0.62) CYP1A2CYP2C19CYP2C9KDM4E
SCHEMBL7825903 0.71 CYP1A2 (0.88) CYP1A2CYP2C19CYP2C9ALDH1A1MAPK1
SCHEMBL9830868 0.70 CA2 (0.53) HDAC4
SCHEMBL1649541 0.69 CYP1A2 (0.55) CYP1A2CYP2C19CYP2C9ALDH1A1MAPK1
Adipic Acid SCHEMBL1648545 0.69 CYP2C19 (0.58) CYP1A2CYP2C19CYP2C9ALDH1A1TBXAS1
SCHEMBL5857603 0.68 CA2 (0.55)
SCHEMBL7032674 0.68 CA2 (0.50) CYP1A2CYP2C19KDM4EMPOCYP3A4
SCHEMBL7032672 0.68 CA2 (0.50) CYP1A2CYP2C19KDM4EMPOCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070026078-A1 Pharmaceutical co-crystal compositions TRANSFORM PHARMACEUTICALS, INC. (US) 2007-02-01 US claimed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 US disclosed
US-20100311701-A1 Pharmaceutical Co-Crystal Compositions TRANSFORM PHARMACEUTICALS, INC (US) 2010-12-09 US disclosed
US-20070026078-A1 Pharmaceutical co-crystal compositions TRANSFORM PHARMACEUTICALS, INC. (US) 2007-02-01 US disclosed